Tymora Analytical Operations Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $2.87M
Latest Deal Amount
  • Investors
  • 4

Tymora Analytical Operations General Information

Description

Provider of new research products and reagents to research and development organizations within the life sciences market. The company has developed a set of novel laboratory technologies for the analysis of protein phosphorylation in the field of life sciences and proteomics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 3495 Kent Avenue
  • Suite E400
  • West Lafayette, IN 47906
  • United States
+1 (765) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tymora Analytical Operations Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2016 $2.87M 0000 Completed Generating Revenue
1. Accelerator/Incubator 10-Mar-2015 0000 0000 Completed Startup
To view Tymora Analytical Operations’s complete valuation and funding history, request access »

Tymora Analytical Operations Executive Team (2)

Name Title Board Seat Contact Info
Anton Iliuk Ph.D Co-Founder, President & Chief Technology Officer
W. Andy Tao Ph.D Co-Founder & Chief Scientific Officer
To view Tymora Analytical Operations’s complete executive team members history, request access »

Tymora Analytical Operations Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Purdue Research Foundation Limited Partner Minority 000 0000 000000 0
To view Tymora Analytical Operations’s complete investors history, request access »